A 75-year-old female presented with progressive dyspnoea NYHA functional class IV. Echocardiography revealed moderate regurgitation and severe stenosis (P mean 13 mmHg) of degenerated mitral valve (MV) with severe mitral annular calcification (MAC) (Panel A). Multislice computed tomography (MSCT) showed a ring-like pattern of the MAC with involvement of both MV leaflets (Panel B, MSCT of the MV annulus: inner diameter 28 × 23 mm, perimeter 82 mm). Owing to severe co-morbidities (STS score 13.8%) and a history of surgical aortic valve replacement in 2008, the Heart Team decided to perform transcatheter MV replacement (TMVR) via transapical access with implantation of a balloon-expandable Edwards-SAPIEN XT prosthesis (Edwards Lifesciences, Irvine, USA). For proper MV annular sizing, we used a 24-mm balloon valvuloplasty catheter (Osypka AG, Rheinfeld-Herten, Germany) for preparatory balloon mitral valvuloplasty with simultaneous left ventriculography (Panel C). Since no contrast regurgitation into the left atrium was obvious, we selected a 26-mm transcatheter heart valve (THV), which was implanted under transoesophageal echocardiographic (TEE) and fluoroscopic guidance (Panel D). Three dimensional-TEE and fluoroscopy confirmed proper TAVR valve positioning with only mild paravalvular MV regurgitation after valve expansion and acute reduction of the transvalvular mean pressure gradient to 3 mmHg (Panel E, two dimensional-TEE with MV regurgitation grade I-II; Panel F, 3D-TEE en-face-view of the acute procedural result with Doppler trace of the MV). After the procedure, the patient improved with a decrease in functional NYHA class to grade II. This case demonstrates that MV disease with calcified MV annulus may be treated by TMVR in selected high-risk patients.
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